J&J recalls 40,000 bottles of schizophrenia drugs

NEW YORK Fri Jun 17, 2011 2:44pm EDT

Related Topics

NEW YORK (Reuters) - Johnson & Johnson said on Friday it has recalled 16,000 bottles of its Risperdal schizophrenia treatment and another 24,000 bottles of a generic formulation of the medicine due to consumer reports of odors in the products.

The company -- which has been beset over the past two years with recalls of consumer medicines, prescription drugs and medical devices -- said the latest two recalls stem from odors believed caused by trace amounts of a chemical called TBA found in pallets used to transport and store materials.

J&J last year recalled a number of over-the-counter drugs -- including its Tylenol and Motrin painkillers and its Benadryl allergy treatment -- because of the same musty or moldy odor linked to the chemical.

"While not considered to be toxic, TBA can generate an offensive odor and a very small number of patients have reported temporary gastrointestinal symptoms when taking other products with this odor," J&J said on Friday.

J&J said the recalled generic formulation of Risperdal, known by its chemical name risperidone, was sold by the company's Patriot Pharmaceuticals unit.

J&J, under close federal supervision, is trying to fix quality-control problems at its consumer medicines plants that have triggered most of the company's repeated recalls since late 2009.

(Reporting by Ransdell Pierson, editing by Gerald E. McCormick)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.